Variables | Posttraumatic | Postsurgical | Corneal ulcer-associated | Endogenous | Statistics | P |
---|---|---|---|---|---|---|
246 (68.52%) | 81 (22.56%) | 24 (6.69%) | 8 (2.22%) | |||
Year | ||||||
2014 | 44 (17.89%) | 16 (19.75%) | 1 (4.17%) | 1 (12.50%) | χ2 = 10.28 | 0.592 |
2015 | 58 (23.58%) | 14 (17.28%) | 3 (12.50%) | 1 (12.50%) | ||
2016 | 47 (19.11%) | 19 (23.46%) | 6 (25.00%) | 1 (12.50%) | ||
2017 | 45 (18.29%) | 16 (19.75%) | 5 (20.83%) | 2 (25.00%) | ||
2018 | 52 (21.14%) | 16 (19.75%) | 9 (37.50%) | 3 (37.50%) | ||
Age | 41.67 ± 15.51 | 62.21 ± 17.17 | 58.67 ± 11.94 | 67.13 ± 16.13 | F = 43.04 | < 0.0001 |
≦15 | 15 (6.10%) | 2 (2.47%) | 0 (0.00%) | 0 (0.00%) | χ2 = 134.5 | < 0.0001 |
16–30 | 42 (17.07%) | 5 (6.17%) | 0 (0.00%) | 0 (0.00%) | ||
31–45 | 84 (34.15%) | 3 (3.70%) | 4 (16.67%) | 1 (12.50%) | ||
46–60 | 80 (32.52%) | 17 (20.99%) | 9 (37.50%) | 2 (25.00%) | ||
61–75 | 20 (8.13%) | 33 (40.74%) | 10 (41.67%) | 2 (25.00%) | ||
> 75 | 5 (2.03%) | 21 (25.93%) | 1 (4.17%) | 3 (37.50%) | ||
Sex | ||||||
Male | 219 (89.02%) | 42 (51.85%) | 6 (25.00%) | 4 (50.00%) | χ2 = 84.69 | < 0.0001 |
Female | 27 (10.98%) | 39 (48.15%) | 18 (75.00%) | 4 (50.00%) | ||
Occupation | ||||||
Farmer | 90 (36.59%) | 31 (38.27%) | 16 (66.67%) | 4 (50.00%) | χ2 = 102.7 | < 0.0001 |
Worker | 108 (43.90%) | 9 (11.11%) | 1 (4.17%) | 0 (0.00%) | ||
Student | 20 (8.13%) | 2 (2.47%) | 0 (0.00%) | 0 (0.00%) | ||
The retired | 1 (0.41%) | 16 (19.75%) | 4 (16.67%) | 1 (12.50%) | ||
Office clerks | 10 (4.07%) | 4 (4.94%) | 1 (4.17%) | 0 (0.00%) | ||
Others | 17 (6.91%) | 19 (23.46%) | 2 (8.33%) | 3 (37.50%) | ||
Eye | ||||||
Right | 131 (53.25%) | 48 (59.26%) | 12 (50.00%) | 1 (12.50%) | χ2 = 6.61 | 0.085 |
Left | 115 (46.75%) | 33 (40.74%) | 12 (50.00%) | 7 (87.50%) | ||
Visit time | ||||||
≦7d | 209 (84.96%) | 60 (74.07%) | 6 (25.00%) | 6 (75.00%) | χ2 = 47.41 | < 0.0001 |
> 7d | 37 (15.04%) | 21 (25.93%) | 18 (75.00%) | 2 (25.00%) | ||
Therapy | ||||||
MT | 13 (5.28%) | 9 (11.11%) | 3 (12.50%) | 1 (12.50%) | χ2 = 137.3 | < 0.0001 |
MT + IVA | 36 (14.63%) | 14 (17.28%) | 2 (8.33%) | 2 (25.00%) | ||
MT + IVA + PPV | 186 (75.61%) | 53 (65.43%) | 1 (4.17%) | 2 (25.00%) | ||
Enucleation | 11 (4.47%) | 5 (6.17%) | 18 (75.00%) | 3 (37.50%) | ||
COculture(+)* | 90 (40.72%) | 40 (54.05%) | 7 (58.33) | 4 (50.00%) | ||
G+ bacteria | 74 (82.22%) | 33 (82.5%) | 4 (57.14%) | 4 (100.00%) | χ2 = 40.42 | 0.0004 |
G- bacteria | 9 (10.00%) | 7 (17.5%) | 0 (0.00%) | 0 (0.00%) | ||
Mixed bacteria | 4 (4.44%) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | ||
Fungus | 3 (3.33%) | 0 (0.00%) | 3 (42.86%) | 0 (0.00%) | ||
VA | ||||||
pre-therapy | 2.22 ± 0.63 | 2.30 ± 0.52 | 2.80 ± 0.35 | 2.44 ± 0.70 | F = 7.198 | < 0.0001 |
≦2.3 | 195 (79.27%) | 68 (83.95%) | 22 (91.67%) | 7 (87.50%) | χ2 = 3.307 | 0.3467 |
> 2.3 | 51 (20.73%) | 12 (14.81%) | 2 (8.33%) | 1 (12.50%) | ||
post- therapy | 1.59 ± 0.80 | 1.53 ± 0.76 | 2.64 ± 0.69 | 2.34 ± 0.87 | F = 15.82 | < 0.0001 |
≦2.3 | 78 (31.71%) | 21 (25.93%) | 19 (79.17%) | 6 (75.00%) | χ2 = 30.2 | < 0.0001 |
> 2.3 | 168 (68.29%) | 59 (72.84%) | 5 (20.83%) | 2 (25.00%) | ||
VA improved | ||||||
Not improved | 80 (32.52%) | 15 (18.52%) | 19 (79.17%) | 6 (75.00%) | χ2 = 36.96 | < 0.0001 |
Improved | 166 (67.48%) | 66 (81.48%) | 5 (20.83%) | 2 (25.00%) | ||
Wound location** | ||||||
Zone I | 197 (80.08%) | – | – | – | ||
Zone II | 44 (17.89%) | – | – | – | ||
Zone III | 5 (2.03%) | – | – | – | ||
IOFB** | ||||||
NO | 159 (64.63%) | – | – | – | ||
Metal | 69 (28.05%) | – | – | – | ||
Non-metal | 18 (7.32%) | – | – | – |